Summary
Unable to verify most claims against the provided FDA label excerpts because the label text supplied pertains to cetirizine hydrochloride oral solution (and to specific pediatric ages), while multiple user claims reference cetirizine 10 mg tablets and several dose/use/general safety timing statements are not supported by the provided excerpts. Multiple claims about administration/dosing timing, onset of relief, and tablet-specific dosing frequency are unsupported/uncorroborated.
Category Scores
Accurate Statements
Cetirizine is an antihistamine.
Clinical Pharmacology (Mechanism of Actions): 'Cetirizine, a human metabolite of hydroxyzine, is an antihistamine; ... mediated via selective inhibition of peripheral H1 receptors.'
Cetirizine blocks the effects of histamine.
Clinical Pharmacology (Mechanism of Actions): 'principal effects are mediated via selective inhibition of peripheral H1 receptors.'
Blocking histamine effects helps reduce symptoms such as itching, sneezing, and watery eyes.
Indications and Usage: 'symptoms treated effectively include sneezing, rhinorrhea, postnasal discharge, nasal pruritus, ocular pruritus, and tearing' for perennial allergic rhinitis; and 'significantly reduces ... pruritus' for chronic idiopathic urticaria.
Common side effects of cetirizine include sleepiness or drowsiness.
Warnings and Precautions: 'occurrence of somnolence has been reported'; Adverse Reactions: 'somnolence appeared to be dose-related.'
People who feel sleepy after taking cetirizine should avoid driving or operating machinery.
Warnings and Precautions: 'due caution should therefore be exercised when driving a car or operating potentially dangerous machinery.'
Caution is advised with alcohol or other medications that cause sedation when taking cetirizine.
Warnings and Precautions: 'Concurrent use ... with alcohol or other CNS depressants should be avoided because additional reductions in alertness... may occur.'
Unsupported Statements
Cetirizine 10 mg tablets are used to treat allergy symptoms caused by histamine.
Provided label excerpts describe indications for cetirizine hydrochloride (oral solution) for perennial allergic rhinitis and chronic idiopathic urticaria; no tablet strength ('10 mg tablets') and no explicit phrase 'caused by histamine' in the provided label excerpts.
Cetirizine 10 mg tablets are used to relieve sneezing.
While sneezing is included in symptoms treated for perennial allergic rhinitis, the claim specifies '10 mg tablets' and 'tables'—the provided excerpts are for cetirizine hydrochloride oral solution and do not link this specific tablet strength to that symptom.
Cetirizine 10 mg tablets are used to relieve runny nose.
Rhinorrhea is listed as a symptom treated, but the claim is tablet/10 mg-specific and the provided excerpt does not confirm that exact tablet presentation/strength.
Cetirizine 10 mg tablets are used to relieve itchy nose.
Nasal pruritus is listed, but the claim is tablet/10 mg-specific without support in the provided excerpts.
Cetirizine 10 mg tablets are used to relieve itchy/watery eyes.
Ocular pruritus and tearing are listed, but the claim is tablet/10 mg-specific; provided excerpt does not explicitly support that linkage to '10 mg tablets.'
Cetirizine 10 mg tablets are used to relieve itching associated with allergic conditions.
Pruritus is included for chronic idiopathic urticaria; however, the provided excerpts do not support 'associated with allergic conditions' as phrased, and do not confirm '10 mg tablets.'
Cetirizine tablets are taken by mouth.
Label excerpt provided is for oral solution; the provided excerpt does not explicitly state that cetirizine tablets are taken by mouth.
Many cetirizine 10 mg products are taken once daily.
The provided dosing excerpts are for oral solution with specific pediatric age groups (not for '10 mg products' in general).
Common side effects of cetirizine include dry mouth.
Dry mouth is not listed among adverse events in the provided adverse reaction excerpts.
Common side effects of cetirizine include fatigue.
Fatigue is not listed among adverse events in the provided adverse reaction excerpts.
Cetirizine can cause dizziness.
Dizziness is not listed among adverse events in the provided adverse reaction excerpts.
Cetirizine can cause stomach discomfort.
Abdominal pain is mentioned as treatment-related, but 'stomach discomfort' is not specifically supported by the provided excerpts.
Cetirizine can cause drowsiness in some people.
Somnolence is supported, but the claim is nonspecific and does not match the label's 'somnolence' wording; still, because somnolence is supported, this is treated as only partially supportable. (Marked unsupported because the excerpt does not explicitly state 'drowsiness' as phrased.)
Caution is advised with alcohol or other medications that cause sedation when taking cetirizine.
This is largely supported by the alcohol/CNS depressant warning, but the claim is presented as an absolute caution statement without label phrasing details; however label support exists. (Not added to unsupported list if considered supported. This entry removed.)
People with kidney problems may need dose adjustments with cetirizine.
Kidney impairment/dose adjustment is not addressed in the provided label excerpts.
Cetirizine is cleared by the body through the kidneys.
The provided excerpts do not state renal clearance/elimination.
Combining cetirizine with other medicines that cause sedation can increase drowsiness.
The label supports additional impairment of CNS performance with alcohol or CNS depressants, but the claim specifically uses 'other medicines that cause sedation' and 'increase drowsiness' without label wording.
Other medicines that cause sedation include some sleep aids, anxiety medications, and opioid pain medicines.
The provided label excerpts do not list specific classes such as sleep aids, anxiety medications, or opioids.
If a dose of cetirizine is missed, it should be taken when remembered unless it is close to the next dose.
Missed-dose instructions are not provided in the supplied label excerpts.
Taking more than directed cetirizine can increase the risk of side effects such as marked drowsiness or agitation.
Overdosage/more-than-directed guidance is not provided in the supplied label excerpts.
If cetirizine overdose is suspected, medical advice or urgent care should be sought.
Overdose/suspected overdose instructions are not provided in the supplied label excerpts.
Many people notice symptom relief within about an hour after taking cetirizine.
No onset timing (e.g., within about an hour) is included in the supplied label excerpts.
For once-daily dosing, cetirizine effects last through the day.
The provided excerpts do not state duration of effect through the day.
Contradictions
Important Omissions
Cetirizine labeling in the provided excerpts is indication-specific (perennial allergic rhinitis; chronic idiopathic urticaria in young children), but the claims broadly attribute treatment of 'allergy symptoms' without specifying the labeled conditions.
Importance:
Moderate
The provided dosing excerpt is for cetirizine hydrochloride oral solution with specific pediatric age ranges and dosing regimens; the claims assert general once-daily use for '10 mg products' without age range/dosing regimen support.
Importance:
Moderate
No contraindication statement appears in the AI claims; the label excerpt includes contraindication for known hypersensitivity to cetirizine/hydroxyzine, which is omitted from the response context.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
High
Several claims are unsupported by the provided label excerpts, including kidney-related dose adjustment/clearance, specific sedation-medicine examples, missed-dose and overdose guidance, onset-of-relief timing, and 'effects last through the day.' These could lead to incorrect expectations or medication management.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Multiple unsupported or unverified claims (tablet/10 mg specificity, dosing frequency/duration, kidney clearance/dose adjustment, missed dose/overdose instructions, and specific sedation medication examples) are not supported by the provided FDA label excerpts.
Suggested Improvement
Rephrase to match only provided label-supported content: use label-supported indications (perennial allergic rhinitis symptoms; chronic idiopathic urticaria pruritus/hives in labeled pediatric age range), describe somnolence and driving caution as written, avoid kidney and timing/overdose/missed-dose claims unless supported by additional label text, and remove tablet-10 mg and general once-daily/duration assertions not corroborated by the supplied excerpts.